Effects of Hemoadsorption on Vascular Integrity in Septic Shock
NCT: NCT07711197 · NOT_YET_RECRUITING
Brief Summary
This study aims to investigate the effects of adjunctive CytoSorb hemoadsorption therapy versus standard medical treatment on endothelial dysfunction in patients with refractory septic shock. The investigators hypothesize that hemoadsorption mitigates endothelial and glycocalyx injury by removing inflammatory mediators and other injurious circulating molecules, promoting hemodynamic stabilization.
Frequently Asked Questions
What is Effects of Hemoadsorption on Vascular Integrity in Septic Shock?
Effects of Hemoadsorption on Vascular Integrity in Septic Shock is a clinical trial registered under NCT07711197. Current status: NOT_YET_RECRUITING.
What is the status of NCT07711197?
The current status of NCT07711197 (Effects of Hemoadsorption on Vascular Integrity in Septic Shock) is: NOT_YET_RECRUITING.
When did Effects of Hemoadsorption on Vascular Integrity in Septic Shock start?
Effects of Hemoadsorption on Vascular Integrity in Septic Shock started on 2026-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.